Ascelia Pharma gets US patent for 2nd generation Mangoral

Ascelia Pharma gets US patent for 2nd generation Mangoral Ascelia Pharma AB (publ) (ticker: ACE) today announced that the US Patent Office (USPTO) has issued a new patent covering a second-generation formulation of lead drug candidate Mangoral, currently in the...

Kim Stratton, CEO, resigns from Orphazyme

Kim Stratton, CEO, resigns from Orphazyme Orphazyme A/S (ORPHA.CO) (“Orphazyme”), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announces that Kim Stratton has decided to...